These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34087391)

  • 21. Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway.
    Ibrahim WW; Abdel Rasheed NO
    Inflammopharmacology; 2022 Oct; 30(5):1745-1758. PubMed ID: 35639233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
    Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
    Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats.
    Mahdy HM; Tadros MG; Mohamed MR; Karim AM; Khalifa AE
    Neurochem Int; 2011 Nov; 59(6):770-8. PubMed ID: 21827809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK.
    Habib MZ; Tadros MG; Abd-Alkhalek HA; Mohamad MI; Eid DM; Hassan FE; Elhelaly H; Faramawy YE; Aboul-Fotouh S
    Eur J Pharmacol; 2022 Jul; 927():175046. PubMed ID: 35623405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
    Suganya SN; Sumathi T
    Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways.
    Hamouda HA; Sayed RH; Eid NI; El-Sayeh BM
    Neurochem Res; 2024 Apr; 49(4):1017-1033. PubMed ID: 38184805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
    Binawade Y; Jagtap A
    J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
    Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
    Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.
    Fink KD; Crane AT; Lévêque X; Dues DJ; Huffman LD; Moore AC; Story DT; Dejonge RE; Antcliff A; Starski PA; Lu M; Lescaudron L; Rossignol J; Dunbar GL
    Stem Cells Transl Med; 2014 May; 3(5):620-31. PubMed ID: 24657963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-theanine, a Component of Green Tea Prevents 3-Nitropropionic Acid (3-NP)-Induced Striatal Toxicity by Modulating Nitric Oxide Pathway.
    Jamwal S; Kumar P
    Mol Neurobiol; 2017 Apr; 54(3):2327-2337. PubMed ID: 26957301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymoquinone loaded solid lipid nanoparticles counteracts 3-Nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington's disease.
    Ramachandran S; Thangarajan S
    Metab Brain Dis; 2018 Oct; 33(5):1459-1470. PubMed ID: 29855977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.
    Mealer RG; Murray AJ; Shahani N; Subramaniam S; Snyder SH
    J Biol Chem; 2014 Feb; 289(6):3547-54. PubMed ID: 24324270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington's disease in rats: Role of PI3K/Akt and JAK2/NF-κB signaling pathways.
    Rabie MA; Ghoneim AT; Fahmy MI; El-Yamany MF; Sayed RH
    Chem Biol Interact; 2024 Apr; 393():110957. PubMed ID: 38513929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperine mitigates behavioral impairments and provides neuroprotection against 3-nitropropinoic acid-induced Huntington disease-like symptoms.
    Salman M; Tabassum H; Parvez S
    Nutr Neurosci; 2022 Jan; 25(1):100-109. PubMed ID: 32093571
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia.
    Brugnoli A; Napolitano F; Usiello A; Morari M
    Neurobiol Dis; 2016 Jan; 85():155-163. PubMed ID: 26522958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genistein improves sensorimotor gating: Mechanisms related to its neuroprotective effects on the striatum.
    Menze ET; Esmat A; Tadros MG; Khalifa AE; Abdel-Naim AB
    Neuropharmacology; 2016 Jun; 105():35-46. PubMed ID: 26764242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
    Fotoohi A; Moloudi MR; Hosseini S; Hassanzadeh K; Feligioni M; Izadpanah E
    Neurochem Res; 2021 Jun; 46(6):1372-1379. PubMed ID: 33611726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats.
    Dhadde SB; Nagakannan P; Roopesh M; Anand Kumar SR; Thippeswamy BS; Veerapur VP; Badami S
    Biomed Pharmacother; 2016 Feb; 77():52-8. PubMed ID: 26796265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.